We found that CCL18 administration dramatically enhanced the tumorigenicity of MCF-7 cells serially transplanted with NBFs but had no effect on that of breast cancer xenografts without fibroblasts (Fig. 6A). This evidence concerns the gene CCL18 and breast carcinoma.